skip to Main Content

Bruce D. Levy, MD 

Dr. Levy is the Parker B. Francis Professor of Medicine at Brigham and Women’s Hospital and the Division Chief of the Pulmonary and Critical Care Division. Bruce received his MD from the University of Pennsylvania School of Medicine. He completed his internship and residency in Internal Medicine and his fellowship in Pulmonary and Critical Care at Brigham and Women’s Hospital. He was a post-doctoral fellow in the laboratory of Dr. Charles Serhan.  Research undertaken in the Levy laboratory focuses on the roles of endogenous counter-regulatory mediators in the lung. The lab’s mission is “to identify novel pathways and cellular targets that promote resolution of pulmonary inflammation or injury and to determine roles for naturally-derived, specialized pro-resolving mediators in lung health and disease as well as their potential as templates for rational new drug design.” A list of Dr. Levy’s publications can be found on Pubmed.


Rachel Joan Bolognese

Rachel graduated in May of 2021 from the University of Massachusetts Amherst with a bachelors of science in biology and a minor in history. She joined the Levy Lab as a research assistant following her graduation. In the lab, she works with Elaine Cagnina to research the host immune response to Aspergillus lung injury, specifically focusing on various cytokine production as possible targets for novel therapies. She is applying to medical school next year and hopes to be an emergency room doctor. Email:

Thayse Regina Bruggemann, PhD

Thayse received her PhD in Medical Sciences from School of Medicine of Sao Paulo University – Brazil (June 2017). In June 2017 she joined Levy Lab for a postdoctoral fellowship. Her interest is to extend the knowledge about the connection of the immune system with the specialized pro-resolving mediators pathways in different lung diseases subsets. She is currently working on the in vivo and in vitro roles and mechanisms for phospholipid phosphatase 6 regulation of specific cell functions on macrophages and dendritic cells. A list of Thayse’s publications can be found on Pubmed. Email:

Rebecca Elaine Cagnina, MD, PhD

Elaine received her MD and PhD degrees in 2010 as part of the Medical Scientist Training Program at the University of Virginia.   She subsequently completed residency in Internal Medicine and a fellowship in Pulmonary and Critical Care Medicine at the University of Virginia before joining their faculty in 2016.  She moved to BWH and joined the Levy Lab in 2018.  Her current research investigates the host immune response in a mouse model of Aspergillus lung injury.  More broadly, she is interested in how innate immune cells influence the development of effective adaptive immunity in the context of pulmonary infections with the goal of applying new insights to the development of novel therapies. Email:

Tania Chiha , MD

Tania received her MD in May 2021 from the American University of Beirut, Lebanon. She joined the Levy Lab in September 2021 for a postdoctoral fellowship. She is currently doing translational research aimed at gaining a molecular understanding of severe asthma to apply this knowledge towards novel therapeutic strategies. Tania will apply for residency in Internal Medicine next year to pursue a career in pulmonary and critical care. Email:

Melody Duvall, MD, PhD

Melody received her PhD in Immunology from Oxford University, United Kingdom, in 2006 through the NIH-Oxford Graduate Partnership Program and her MD from Washington University in St. Louis School of Medicine in 2008. She completed her pediatrics residency at Boston Children’s Hospital in 2012 and her pediatric critical care medicine fellowship at Boston Children’s Hospital in 2015. She joined the Levy lab in 2014. Melody is investigating the phenotype and function of innate mediators of immunity (in particular innate lymphoid cells (ILCs), natural killer (NK) cells, and mucosal associated invariant T (MAIT) cells in human children with viral lung infection and respiratory failure.  A list of Melody’s publications can be found on Pubmed. Email:

Nandini Krishnamoorthy, PhD

The overarching theme of Nandini’s research has been the identification of pathways that bridge innate and adaptive immune systems. During her PhD and postdoctoral work, she has been involved in studies that explore this connection along multiple dimensions. She is particularly interested in understanding mechanisms behind regulatory T cells dysfunctional during chronic inflammation. She is currently dissecting the cellular interactions between innate lymphoid cells and regulatory T cells in the setting of Respiratory Syncytial Virus (RSV). A complete list of Nandini’s publications can be found at Pubmed. Email:

Mary Elizabeth Moss, MD, PhD

Liz completed her MD and PhD at Tufts University School of Medicine in 2021 as part of the Medical Scientists Training Program. Her PhD work focused on sex differences in vascular inflammation in atherosclerosis, particularly as it relates to hormone signaling in endothelial cells. She is now a resident in Pediatrics at Boston Children’s Hospital in a research track. She joined Dr. Levy’s lab in the summer of 2022, studying sex differences in various models of lung inflammation including influenza infection and asthma. She plans to continue her research in a Pediatric Pulmonary fellowship in the future.

Julie Nijmeh, PhD

Julie received her PhD in Environmental Health Sciences, Phi Beta Kappa from Bloomberg School of Public Health at Johns Hopkins University studying ischemia-induced angiogenesis in animal models of pulmonary embolism. Prior to that she received her BSc from the American University of Beirut in Biology and her MSc in Molecular Pharmacology and Structural Biology from Thomas Jefferson University studying inhibitors of apoptosis proteins (IAPs) in Drosophila models. Julie has been working in the academic field as a science writer and editor, with expertise in grant writing and project management. Email:

Saïsha Ramdour

Saïsha graduated in December of 2021 from Franklin & Marshall College, Pennsylvania, with a Bachelor of Arts in Neuroscience. She joined the Levy Lab as a research assistant working with Melody Duvall on projects involving the study of lung inflammation in humans, including subjects with severe asthma or  viral respiratory infection. Saïsha will be applying to graduate school after a couple of years gathering research experience in the lab. Email:

Ethan William Smith

Ethan graduated in December of 2021 from the University of Massachusetts Amherst with a Bachelor of Science in Biology. Following his graduation, he joined the Levy Lab as a research assistant. In the lab, he works with Nandini Krishnamoorthy to research pulmonary immune responses to inflammation, specifically the interactions between innate and adaptive immune cells in the setting of Respiratory Syncytial Virus (RSV). Outside of the lab, he enjoys baking and hiking. He plans on applying to medical school next year with the hopes of working in pediatrics. Email:

Yuan Sun, PhD

Yuan received his PhD in Medicine from the University of Cambridge in 2022 and joined the Levy lab as a Postdoctoral Research Fellow in December of that year. He is currently researching resolution in different endotypes of asthma and the role of innate and adaptive immune cells in the resolution process. Email:

Luciana Tavares, PhD

Luciana received her PhD in Immunology from Universidade Federal de Minas Gerais – Brazil in 2018. She joined Dr. Bruce Levy’s lab in 2017, where she did part of her PhD project. Now she is a post-doctoral fellow in the Levy’s lab. Her main interest is to understand the role of inflammation and resolution during lung infections, especially influenza and pneumococcal coinfections. Email:

Hong Yong Peh, PhD

Hong Yong received his PhD in Medicine, majoring in immuno-pharmacology from National University of Singapore (NUS) in 2017. He was awarded the NUS-Overseas Postdoctoral Fellowship at graduation, where he was co-appointed as Senior Tutor in the Department of Pharmacology at Yong Loo Lin School of Medicine, and Postdoctoral Research Fellow at Harvard Medical School, USA. He joined the Levy lab in 2017. His current research projects include allergen and inflammatory mediators induced lung and skin injury, the mechanisms of resolution biology, and the efficacy of specialized pro-resolving mediators in promoting resolution in various tissue injury. A list of Hong Yong’s publications can be found on Pubmed. Email:

Guangli Zhu, MD

Guangli is a senior technician in the Levy Lab. Gualngli received her M.D. from China where she trained in anesthesiology and surgery. She has been working in Dr. Levy’s lab since 2006 on the murine model of asthma and acute lung injury. Guangli is responsible for maintaining lab supply inventory as well as ordering supplies, equipment and reagents for the lab. Email:

Ajantha Nadesalingam, Student, Ontario Science Centre School, Toronto, Canada

Alexandre de Paula Rogerio, Associate Professor, Federal University of Triângulo Mineiro, Sao Paolo, Brazil

Alexander H. Tavares, Graduate School, Boston University, Boston, USA

Anna Planaguma, Research Scientist, Almirall Pharmaceuticals, Barcelona, Spain

Ayşe Kılıҫ, Senior Scientist, Germany

Bakr Jundi, Internal Medicine Resident, SUNY Downstate Health Sciences University, Brooklyn, NY

Braden D. Engstrom, Medical Student, University of Michigan, Ann Arbor, Michigan

Caroline Bonnans, Researcher, INSERM, Montpelier, France

Christianah Tolulope Ademuwagun, Medical Student, Howard University College of Medicine, USA

Cindy Barnig, Assistant Professor, Departement de Pathologie Thoracique – Nouvel Hopital Civil Strasbourg, France

Cindy Hana Okuma, Postdoctoral Research Fellow, – University of Sao Paulo, Sao Paulo, Brazil

David Douda, Research Scientist, Therapeutics R&D, Zymeworks Inc.

Emiko Ono, Postdoctoral scholar, Weill-Cornell Medicine, New York, NY

Fiona A Ringholz, Consultant, Our Lady’s Children Hospital, Dublin, Ireland

Francesca Levi-Schaffer, Professor, The Hebrew University of Jerusalem, Dept. of Pharmacology, Jerusalem, Israel

Frantz Hastrup, Intensivist, Overlake Medical Center, Seattle, WA

Geoffrey Rubin, Internal Medicine Resident, Columbia University College of Physicians & Surgeons, New York, NY

Hiroyuki Seki, Assistant Professor, Keio University, Anesthesiologist, Saiseikai-Chuo Hospital, Tokyo, Japan

Ho Pan (Andy) Sham, Research Scientist, Qu Biologics

Ingibjorg Haroardottier, Professor in Biochemistry and Molecular Biology Biomedical Center, Faculty of Medicine, University of Iceland, Reykjavik

Isabell Baumann, Resident Physician, University of Hamburg

Jack Timmons, Doctor of Pharmacy, UCSF

Jan Hilberath, Deputy Head, ICU, University of Tubingen, Tubingen, Germany

Jennifer Colby, Assistant Professor, University of Texas, MD Anderson Cancer Center

Joanna Barkas, Medical Student, Tufts University

Katherine H. Walker, Instructor in Medicine, Brigham & Women’s Hospital, Boston

Koichi Fukunaga, Assistant Professor, Keio University, Tokyo, Japan

Laila Karra, Post-doctorate scholar, The Hebrew University of Jerusalem, Dept. of Pharmacology, Jerusalem, Israel

Laura Basu, Master’s Degree – Pharmacy, University of Uppsala, Uppsala, Sweden

Lauren Frazer, University of North Carolina, NC, USA

Mary Fuhlbrigge, Medical School, University of Colorado, USA

Michael Pfeffer, Medical School, University of Queensland / Ochsner Health System, New Orleans, LA

Mohib Uddin, Research Scientist, Astra-Zeneca, Stockholm, Sweden

Olaf Eickmeier, Instructor, Goethe University, Frankfurt, Germany

Oliver Haworth, Researcher, William Harvey Research Institute, London, England

Payal Kohli, Cardiology Fellow, University of California San Francisco, San Francisco, CA

Raja-Elie E. Abdulnour, Assistant Professor, Brigham & Women’s Hospital and New England Journal of Medicine, Boston, MA

Rebekah Priluck, Medical Student, University of Nebraska School of Medicine, Omaha, NE

Roisin (Rosie) Reilly, Medical Student, Washington University in St. Louis, St. Louis, MO

Roxanne Croze, Post-doctorate scholar, UCSF, San Francisco

Troy Carlo, Senior Research Scientist, CRISPR Therapeutics, Cambridge MA

Back To Top